NEW YORK, NY – June 4, 2026 — Fullspan Health™, a unified B2B health care platform from RVO Health™, a health technology company, today launched Healthline AI, a conversational AI agent built specifically for health. The launch marks an industry first from an endemic health publisher, and a strategic evolution for Healthline®, moving the brand from trusted health resource to a platform that drives consumer health decisions. Built with clinical guardrails, triage protocols and privacy protections for consumers, Healthline AI gives partners a responsible way to support consumers as they seek health information and next steps.
Healthline AI functions as an intelligent health companion, helping consumers ask health questions, explore medically reviewed guidance and connect to relevant resources. The experience is designed to help people take the next step in their health journey, from finding condition-specific information, accessing tools, tailored resources and eventually it will offer prescription savings, support in choosing the right healthcare provider, and an ability to book care including virtual care. Available now on Healthline.com, Healthline AI draws exclusively from Fullspan Health’s medically reviewed properties, including Healthline, Healthgrades®, Medical News Today® and Psych Central®. Healthline AI is set to scale across Fullspan Health’s audience of 63 million monthly unique users.
Unlike general-purpose LLMs, which have raised concerns about health accuracy and misinformation, Healthline AI is grounded in more than two decades of Fullspan Health’s editorial standards, medical review processes and consumer trust.
This comes at an important time as physicians and patients are increasingly open to using AI as part of their health information journey. Healthline's own consumer research found that 90% of survey respondents were interested in a conversational health experience from Healthline, and nearly 70% said they would find it more trustworthy than ChatGPT. According to the AMA's 2026 physician survey 68% of doctors feel positively about their patients asking AI about medications, and 64% welcome patients using AI for general health questions.
"We listened to what our audience said they wanted, and we built it," said Christine Maguire, EVP and Chief Business Officer, Fullspan Health. "It is exciting to be first-to-market with a brand-safe, AI agent for health to help people go from awareness to action within the most trusted and popular health portfolio. This is just one of many tech innovations we will be introducing as a partner solution this year."
Healthline AI launches on Type 2 diabetes content, with additional conditions to follow. For pharmaceutical and health system partners, the experience offers brand-safe placement when consumers are most actively seeking health guidance. Partners can also benefit from its compliance framework built for regulated advertisers.
Healthline AI is an information companion, not a clinician and the system is engineered to hold that line, consistently and at scale. Healthline has invested significantly in a proprietary guardrail framework that governs every interaction: ensuring responses are educational, non-diagnostic, and calibrated to the nature of each user's need. The experience is not yet available in California.
About Fullspan Health
Fullspan Health is a unified B2B health care platform from RVO Health, a health technology company backed by the nation’s largest consumer health portfolio, helping healthcare businesses engage consumers across the full continuum of care, from patient finding and engagement to pharmacy, care services, and medication adherence. Leveraging the authority of Healthline Media and Healthgrades, Fullspan Health combines medically reviewed content, innovative agentic digital tools, and data-driven insights to deliver a seamless, patient-centric experience.
